CXCL10, as a novel serum marker for vitiligo activity, plays a critical role in mediating CD8+ T cells skin trafficking, thus promoting the disease progression and maintenance of depigmentation (Rashighi et al., 2014). The gene discussed is CXCL10; the disease is vitiligo.